drugset / Trial / NCT04146129
A Phase 1 Study of CDX-0159
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a study to determine the safety of CDX-0159 in healthy subjects.
Timeline
- Start
- 2019-10-29
- Primary completion
- 2020-04-06
- Completion
- 2020-06-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | barzolvolimab | Monoclonal antibody | — | — |
Indications
No indication recorded.